Does Stage 1 Hypertension in Early Pregnancy Confer an Increased Risk for Preeclampsia?
BACKGROUND AND PURPOSE:
In 2017, criteria for diagnosing hypertension in the general population changed (ACC and AHA Task Force)
Prehypertension category was broken in to the following 2 categories
Elevated BP: SBP 120 to 129 mm Hg and DBP <80 mm Hg
Stage 1 hypertension: SBP 130 to 139 mm Hg or DBP 80 to 89 mm Hg
Stage 2 hypertension defined as levels >Stage 1 (SBP ≥140 mm Hg DBP ≥90 mm Hg)
Sutton et al. (Obstetrics & Gynecology, 2020) investigated whether women with early pregnancy elevated BP or stage 1 hypertension are at increased risk for preeclampsia and related maternal and neonatal morbidity
Clinical cohort study
Aggregate of prenatal and delivery health records (2015 to 2018)
≥2 prenatal appointments <20 weeks
Early pregnancy BP definition: Average BP <20 weeks
Women were classified according to current guidelines as having
Stage 1 hypertension
Stage 2 hypertension
Severe maternal morbidity defined as one of the following
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
NOT ENOUGH CME HOURS
It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan